Miniaturized Surgical Robotic Instruments Expand the Possibilities of Surgical Interventions

Food and Healthcare Press Releases Wednesday December 6, 2017 09:35
CALCI, Italy--6 Dec--PRNewswire/InfoQuest
  • MMI S.r.l. Unveils World's Smallest Robotic Wrist

Medical Microinstruments S.r.l. (MMI), a developer of novel robotic solutions for unmet medical needs, today reveals its robotic platform specifically designed for open microsurgery. The platform allows the surgeon to control two tiny articulated microinstruments that simplify reconstruction procedures after traumatic injuries as well as after tumor removal in soft tissue and bones, and offers the potential for improved surgical success rates and patient outcomes.

(Logo: http://mma.prnewswire.com/media/614046/MMI_Srl_Logo.jpg )
(Photo: http://mma.prnewswire.com/media/614047/MMI_Srl_Robotic_Wrist.jpg )
Video - https://www.youtube.com/watch?v=CTg262fMap0

MMI's instruments are equipped with the smallest articulated wrist having a 3-millimeter outer diameter and tips just 150 micron in width. The wrist is the key to performing robotic microsurgery in real clinical settings and allows easy manipulation of small sutures, from 9-0 to 12-0 in size.

"Thanks to the use of advanced materials and novel microfabrication processes, we have designed the smallest articulated wrist to provide microsurgeons unique instrument dexterity and robotic precision," said Massimiliano Simi, Co-founder and VP R&D.

The surgeon operates the microinstruments while sitting at the surgical bedside and looking through the operating microscope. MMI's robotic platform captures surgeon's hand movements and a scaled-down motion is imposed on the microinstruments.

"We have developed this groundbreaking technology together with microsurgeons from the product's conception and the positive feedback and response that we've received along the way has really been overwhelming and led us to believe that we are on the right track in developing a robot by and for microsurgeons," said Hannah Teichmann, Co-founder and VP Clinical.

Prof. Marco Innocenti, Chief of Plastic and Reconstructive Microsurgery at Careggi University Hospital in Florence and MMI's Clinical Advisor, who has presented preclinical work with MMI's robot at 9th Congress of World Society for Reconstructive Microsurgery in Seoul, including 0.35mm arterial robotic anastomosis, remarked:

"In my opinion, the MMI robotic platform will push the frontier of microsurgery forward and beyond the capabilities of the human hand, thus allowing more surgeons to perform more complex procedures but also enabling supermicrosurgery, such as lymph reconstruction, for the more expert ones."

MMI's President and Co-founder, Giuseppe Maria Prisco, estimates the potential annual market opportunity to be in the order of $2.5 billion.
Related links:
http://www.mmimicro.com
Watch the company video on http://www.mmimicro.com/mmi-video
About:

Medical Microinstruments S.r.l. (MMI), founded in 2015, is based in Calci (PI), Italy. The company's mission is to help more surgeons around the world to offer more advanced procedures, while reducing costs for patients, hospitals and for society at large.

Contact:
Vanya Petrova
Relationship Manager
vanya.petrova@mmimicro.com
+39-348-5441025
Source: MMI Srl

Latest Press Release

Equashield Reports Surging Growth In Both U.S. And International Markets, 40 Percent Year-over-year Increase In Revenues

Company expects growth to accelerate in 2018, due to worker safety regulation, increased market understanding of advantages of Equashield truly-closed system Equashield ( http://www.equashield.com ), a leading provider of Closed System Transfer Devices...

HTC VIVE And World Economic Forum Partner For The Future Of The VR/AR For Impact Initiative

- New "VR/AR for Impact" Content Designed to Help Drive Positive Change Across the Globe Showcased at World Economic Forum 2018 HTC VIVE(TM), the leader in premium Virtual Reality (VR), today announced a partnership with the World Economic Forum (WEF)...

Historic Deal Signed Between Panacea Biotec and Serum Institute of India

Panacea Biotec Ltd. (PBL), India's leading biopharmaceutical company and among the largest manufacturer of vaccines, has signed two long-term collaboration agreements with Serum Institute of India Pvt. Ltd. (SII), world's largest manufacturer of vaccines...

The Consumer Health of Merck Walks the Talk with its WE100 Movement

- Consumer Health accelerates its WE100(R) movement by launching new partnership programme with pharmacists in the UK on enabling 100 years of healthy living - Femibion(R) celebrates working mums with new "MumPlus" campaign - Expansion of Vitamin D brand...

Mindray launches BeneVision N1 for uninterrupted monitoring during intra and out-of-hospital patient transport

The revolutionary transport solution extends intelligent monitoring to out-of-hospital transport settings such as ambulances, helicopters, and civic flights. Mindray, a global medical equipment solution provider, announced the release of BeneVision N1...

Related Topics